miR-489 Confines Uncontrolled Estrogen Signaling through a Negative Feedback Mechanism and Regulates Tamoxifen Resistance in Breast Cancer.
miR-489 Confines Uncontrolled Estrogen Signaling through a Negative Feedback Mechanism and Regulates Tamoxifen Resistance in Breast Cancer.
复制标题
miR - 489通过负反馈机制限制不受控制的雌激素信号传导,并调节乳腺癌中的他莫昔芬耐药性。
DOI:
10.3390/ijms23158086
复制
发表时间:
2022-07-22
影响因子:
5.6
通讯作者:
Chen, Hexin
中科院分区:
文献类型:
--
作者:
Soni, Mithil;Saatci, Ozge;Gupta, Gourab;Patel, Yogin;Raja, Manikanda Raja Keerthi;Li, Jie;Liu, Xinfeng;Xu, Peisheng;Wang, Hongjun;Fan, Daping;Sahin, Ozgur;Chen, Hexin
Approximately 75% of diagnosed breast cancer tumors are estrogen-receptor-positive tumors and are associated with a better prognosis due to response to hormonal therapies. However, around 40% of patients relapse after hormonal therapies. Genomic analysis of gene expression profiles in primary breast cancers and tamoxifen-resistant cell lines suggested the potential role of miR-489 in the regulation of estrogen signaling and development of tamoxifen resistance. Our in vitro analysis showed that loss of miR-489 expression promoted tamoxifen resistance, while overexpression of miR-489 in tamoxifen-resistant cells restored tamoxifen sensitivity. Mechanistically, we found that miR-489 is an estrogen-regulated miRNA that negatively regulates estrogen receptor signaling by using at least the following two mechanisms: (i) modulation of the ER phosphorylation status by inhibiting MAPK and AKT kinase activities; (ii) regulation of nuclear-to-cytosol translocation of estrogen receptor α (ERα) by decreasing p38 expression and consequently ER phosphorylation. In addition, miR-489 can break the positive feed-forward loop between the estrogen-Erα axis and p38 MAPK in breast cancer cells, which is necessary for its function as a transcription factor. Overall, our study unveiled the underlying molecular mechanism by which miR-489 regulates an estrogen signaling pathway through a negative feedback loop and uncovered its role in both the development of and overcoming of tamoxifen resistance in breast cancers.
登录
查看更多内容
影响因子:
11.5
作者:
Miller, Philip C.;Clarke, Jennifer;El-Ashry, Dorraya
通讯作者:
El-Ashry, Dorraya
影响因子:
45.3
作者:
Gutierrez, MC;Detre, S;Dowsett, M
通讯作者:
Dowsett, M
DOI:
10.1073/pnas.0906947106
发表时间:
2009-09-15
影响因子:
11.1
作者:
Castellano, Leandro;Giamas, Georgios;Stebbing, Justin
通讯作者:
Stebbing, Justin
影响因子:
8
作者:
Lo, P-K;Kanojia, D.;Liu, X.;Singh, U. P.;Berger, F. G.;Wang, Q.;Chen, H.
通讯作者:
Chen, H.
影响因子:
--
作者:
Frigo, DE;Basu, A;Burow, ME
通讯作者:
Burow, ME